Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up,…
This 2012 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AF and to report the findings of a Task Force, convened by the Heart Rhythm Society, the European Heart Rhythm Association, and the European Cardiac Arrhythmia Society and charged with defining the indications, techniques, and outcomes of this procedure.
HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm…
Guidelines on management (diagnosis and treatment) of syncope.
Table of contents Preamble Scope of the document: Classification, epidemiology and prognosis and diagnosis strategy of evaluation, method, and findings.
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.
PVI with radiofrequency ablation appears to be a feasible first-line approach for treating patients with symptomatic AF, and improvement in quality of life of patients in the PVI group was significantly better than the improvement in the antiarrhythmic drug group in 5 subclasses of the Short-Form 36 health survey.
Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.
Pulmonary-vein isolation was superior to atrioventricular-node ablation with biventricular pacing in patients with heart failure who had drug-refractory atrial fibrillation.
Left Atrial Appendage: An Underrecognized Trigger Site of Atrial Fibrillation
Isolation of the LAA could achieve freedom from atrial fibrillation in patients presenting for a repeat procedure when arrhythmias initiating from this structure are demonstrated.
Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
In patients with ARVC/D, ICD therapy provided life-saving protection by effectively terminating life-threatening ventricular arrhythmias as well as identifying patients who were prone to ventricular fibrillation/flutter on the basis of clinical presentation.
Guidelines on management (diagnosis and treatment) of syncope--update 2004.